Clincosm LogoSign in Get a demo

mss

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)

Not yet recruiting
  • MSS
  • Rectal Cancer
  • Sintilimab with Interleukin-2
  • (no location specified)
Nov 1, 2023

Colorectal Cancer, Liver Metastases, MSS Trial (Sinti+Rego+Cele)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • (no location specified)
Jul 3, 2023

Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)

Not yet recruiting
  • Locally Advanced
  • +3 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital Southern Medical University
May 17, 2023

Rectal Cancer, MSS Trial in Beijing (Cadonilimab, Oxaliplatin, Capecitabine)

Recruiting
  • Rectal Cancer
  • MSS
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Apr 13, 2023

Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in United States (RP2, RP3, atezolizumab)

Not yet recruiting
  • Refractory Metastatic Colorectal Cancer
  • +2 more
  • RP2
  • +3 more
  • Los Angeles, California
  • +5 more
Feb 24, 2023

pMMR, MSS, MSI-L Trial (Serplilumab, Capecitabine, Oxaliplatin)

Not yet recruiting
  • pMMR
  • +3 more
  • (no location specified)
Feb 19, 2023

Colorectal Cancer, MSS, Stage IV Colon Cancer Trial in Belgium, Switzerland, United States (ATP128, BI 754091, VSV-GP128)

Recruiting
  • Colorectal Cancer
  • +5 more
  • Scottsdale, Arizona
  • +10 more
Aug 15, 2022

Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • MSS
  • Heidelberg, Germany
    National Center for Tumor Diseases, University Hospital Heidelbe
May 17, 2022

Metastatic Colorectal Cancer, pMMR, MSS Trial in France (Atezolizumab, Therasphere, XELOX)

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Amiens, France
  • +18 more
Mar 23, 2022

MSS, RAS-mutant Colorectal Cancer Trial in Worldwide (binimetinib, nivolumab, ipilimumab)

Completed
Has Results
  • MSS
  • RAS-mutant Colorectal Cancer
  • Los Angeles, California
  • +49 more
Dec 8, 2021

MSS, pMMR, Metastatic Colorectal Adenocarcinoma Trial in Shenyang (TKI ± anti-PD-1 antibody)

Recruiting
  • MSS
  • +2 more
  • TKI ± anti-PD-1 antibody
  • Shenyang, Liaoning, China
    Cancer Hospital of China Medical University/Liaoning Cancer Hosp
Sep 28, 2021

Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in Hangzhou (Bevacizumab, Tripleitriumab)

Unknown status
  • Refractory Metastatic Colorectal Cancer
  • +2 more
  • Hangzhou, Zhejiang, China
    the Second Affiliated Hospital of Medical College of Zhejiang Un
Sep 15, 2020

Colorectal Cancer Metastatic, MSS Trial in Guangzhou (Regorafenib and Nivolumab in Combination with Radiotherapy, Radiation

Unknown status
  • Colorectal Cancer Metastatic
  • MSS
  • Regorafenib and Nivolumab in Combination with Radiotherapy
  • Radiation therapy
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Sep 16, 2019